35 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Selenophene-containing inhibitors of type IIA bacterial topoisomerases.

Achillion Pharmaceuticals
In vitro antituberculosis activities of ACH-702, a novel isothiazoloquinolone, against quinolone-susceptible and quinolone-resistant isolates.

Achillion Pharmaceuticals
Isothiazolopyridones: synthesis, structure, and biological activity of a new class of antibacterial agents.

Achillion Pharmaceuticals
Isothiazoloquinolones containing functionalized aromatic hydrocarbons at the 7-position: synthesis and in vitro activity of a series of potent antibacterial agents with diminished cytotoxicity in human cells.

Achillion Pharmaceuticals
Biological evaluation of isothiazoloquinolones containing aromatic heterocycles at the 7-position: In vitro activity of a series of potent antibacterial agents that are effective against methicillin-resistant Staphylococcus aureus.

Achillion Pharmaceuticals
Exploration of the activity of 7-pyrrolidino-8-methoxyisothiazoloquinolones against methicillin-resistant Staphylococcus aureus (MRSA).

Achillion Pharmaceuticals
Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.

Achillion Pharmaceuticals
Isothiazoloquinolones with enhanced antistaphylococcal activities against multidrug-resistant strains: effects of structural modifications at the 6-, 7-, and 8-positions.

Achillion Pharmaceuticals
Inhibitors of SARM1

Disarm Therapeutics
BIOPROBES FOR LYSYL OXIDASES AND USES THEREOF

Pharmaxis
Tetrazole derivatives as TRPA1 inhibitors

Boehringer Ingelheim International
COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

Vertex Pharmaceuticals
TYK2 inhibitors and uses thereof

Nimbus Lakshmi
Isoquinoline derivatives and use thereof

Purdue Pharma
Compounds useful for treating gastrointestinal tract disorders

Ardelyx
Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof

Pharmaxis
Selective inhibitors of protein arginine methlytransferase 5 (PRMT5)

Prelude Therapeutics
Indole Chloropyridinyl Ester-Derived SARS-CoV-2 3CLpro Inhibitors: Enzyme Inhibition, Antiviral Efficacy, Structure-Activity Relationship, and X-ray Structural Studies.

Purdue University
1 H-pyrazol-1-yl-thiazoles as inhibitors of lactate dehydrogenase and methods of use thereof

The Trustees of The University of Pennsylvania
Potent and selective inhibitors of monoamine transporters; method of making; and use thereof

The United States of America, As Represented By The Secretary, Department of Health and Human Services
1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as P38 MAP knase inhibitors

Respivert
Heterocyclic inhibitors of ATR kinase

University Of Texas
Pyrimido-pyridazinone compounds and methods of use thereof

Asan Biosciences
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Eli Lilly
Thieno- and furo[2,3-d]pyrimidine-2,4[1H,3H]-dione derivatives

Hydra Biosciences
Inhibition of the alpha- and beta-carbonic anhydrases from the gastric pathogen Helycobacter pylori with anions.

Universit�� Degli Studi Di Firenze
17a-hydroxylase/C17,20-lyase inhibitors

Novartis
Substituted cycloocta[5,6]pyrido[4,3,2-de]phthalazines as PARP inhibitors

Beigene
Mechanism of Flavoprotein l-6-Hydroxynicotine Oxidase: pH and Solvent Isotope Effects and Identification of Key Active Site Residues.

University of Texas Health Science Center
Nitrogen-containing saturated heterocyclic compound

Mitsubishi Tanabe Pharma
Methods for increasing the stabilization of hypoxia inducible factor-α

Aerpio Therapeutics
Molecular Mechanism for Isoform-Selective Inhibition of Acyl Protein Thioesterases 1 and 2 (APT1 and APT2).

University of Michigan
The A128T resistance mutation reveals aberrant protein multimerization as the primary mechanism of action of allosteric HIV-1 integrase inhibitors.

The Ohio State University
1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders

Neurovance
4-arylazo-3,5-diamino-1H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects.

Palacky University